脂肪组织
炎症
免疫系统
先天性淋巴细胞
T细胞
免疫学
平衡
生物
脂肪组织巨噬细胞
先天免疫系统
内分泌学
内科学
细胞生物学
医学
白色脂肪组织
作者
Christian Schwartz,Viviane Schmidt,Andrea Deinzer,Heike C. Hawerkamp,Emily Hams,Jasmin Bayerlein,Ole Röger,Moritz Bailer,Christian Krautz,Amr El Gendy,Moustafa Elshafei,Helen Heneghan,Andrew E. Hogan,Donal O’Shea,Padraic G. Fallon
出处
期刊:Science Translational Medicine
[American Association for the Advancement of Science (AAAS)]
日期:2022-03-09
卷期号:14 (635)
被引量:33
标识
DOI:10.1126/scitranslmed.abj6879
摘要
Obesity has become a major health problem in the industrialized world. Immune regulation plays an important role in adipose tissue homeostasis; however, the initial events that shift the balance from a noninflammatory homeostatic environment toward inflammation leading to obesity are poorly understood. Here, we report a role for the costimulatory molecule programmed death-ligand 1 (PD-L1) in the limitation of diet-induced obesity. Functional ablation of PD-L1 on dendritic cells (DCs) using conditional knockout mice increased weight gain and metabolic syndrome during diet-induced obesity, whereas PD-L1 expression on type 2 innate lymphoid cells (ILC2s), T cells, and macrophages was dispensable for obesity control. Using in vitro cocultures, DCs interacted with T cells and ILC2s via the PD-L1:PD-1 axis to inhibit T helper type 1 proliferation and promote type 2 polarization, respectively. A role for PD-L1 in adipose tissue regulation was also shown in humans, with a positive correlation between PD-L1 expression in visceral fat of people with obesity and elevated body weight. Thus, we define a mechanism of adipose tissue homeostasis controlled by the expression of PD-L1 by DCs, which may be a clinically relevant finding with regard to immune-related adverse events during immune checkpoint inhibitor therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI